Home
Conference Highlights
View All Conference Highlights
Year in Review / Wrap-Ups
Wrap-Ups
Year in Review
Contact Us
Conference Highlights
American Society of Clinical Oncology (ASCO)
ASCO 2021 – Breast Cancer
ASCO 2021 – Breast Cancer
Assessment of Oncology Patient Satisfaction with Telehealth Visits
ASCO 2021 – Breast Cancer
Telehealth visits provide increased access to care for oncology patients across multiple demographics with reported high patient satisfaction with level of care.
Read More ›
Inflammatory Responses to Neoadjuvant Chemotherapy Can Be Regulated by Moderate Physical Exercise Prior to Surgery
ASCO 2021 – Breast Cancer
Moderate physical activity reduced the inflammatory response triggered by neoadjuvant chemotherapy in breast cancer patients prior to surgery. The benefit appears to be lost after surgery.
Read More ›
Assessment of Factors That Influence Psychosocial Function in Breast Cancer Patients After Treatment
ASCO 2021 – Breast Cancer
Diverse factors contribute to shifts in psychosocial function in breast cancer patients after treatment. Understanding these factors provides opportunities for patients to receive more holistic care.
Read More ›
Identification of Biomarkers for HER2-Negative Advanced Breast Cancer Is Influenced by Race: A Real-World Study
ASCO 2021 – Breast Cancer
Actionable biomarkers associated with directed treatment to prevent or reverse symptoms in African Americans with advanced-stage breast cancer may reduce mortality rates.
Read More ›
Treatment with Alpelisib plus Fulvestrant Achieves Long-Term Disease Control in Endocrine-Resistant (HR-Positive/HER2-Negative) Advanced Breast Cancer
ASCO 2021 – Breast Cancer
The SOLAR-1 and X2101 trials demonstrate long-term disease control can be attained for ≥18 months with alpelisib plus fulvestrant in patients with hard-to-treat HR-positive/HER2-negative advanced breast cancer.
Read More ›
Behavioral Interventions Demonstrate Improved Long-Term Adherence to Adjuvant Endocrine Therapy Among Women with HR-Positive Breast Cancer
ASCO 2021 – Breast Cancer
Many women with HR-positive breast cancer contend with emotional distress during prolonged adjuvant endocrine therapy. Behavioral interventions show promise as effective strategies to reduce stress and improve adherence to therapy.
Read More ›
Need for Improved Access to Cancer Screening Tools for Minorities with Socioeconomic Barriers to Medical Care
ASCO 2021 – Breast Cancer
Low socioeconomic status is associated with delayed access to age-appropriate cancer screenings due to cost of care.
Read More ›
Novel and Clinically Relevant Measure of Perceived Fatigability Reveals Benefit of Exercise in Breast Cancer Survivors
ASCO 2021 – Breast Cancer
Perceived fatigability may be a more clinically relevant measurement of the effectiveness of exercise intervention on reducing fatigue among survivors of breast cancer.
Read More ›
Association of Stage of Breast Cancer Diagnosis and Socioeconomic Status in French Women
ASCO 2021 – Breast Cancer
Advanced-stage diagnosis of breast cancer is associated with deprived-rural socioeconomic status in French women.
Read More ›
Alpelisib Overcomes Resistance to CDK4/6 Inhibitors in HR-Positive/HER2-Negative Advanced Breast Cancer Patients
ASCO 2021 – Breast Cancer
Alpelisib may overcome resistance to CDK4/6 inhibitors in HR-positive/HER2-negative advanced breast cancer patients with shorter exposure to prior CDK4/6 inhibitor treatment.
Read More ›
Page 1 of 2
1
2
Conference Correspondent Coverage is Brought to You by the Publishers of:
Learn more about our family of publications.
View Our Publications
Home
Conference Highlights
View All Conference Highlights
Year in Review / Wrap-Ups
Wrap-Ups
Year in Review
Contact Us